Literature DB >> 18599503

Endothelial EphA receptor stimulation increases lung vascular permeability.

Jacqueline Larson1, Stacey Schomberg, William Schroeder, Todd C Carpenter.   

Abstract

Mediators of angiogenesis such as VEGFs and angiopoietins may regulate pulmonary vascular permeability under normal and pathological conditions. Ephrin family receptor tyrosine kinases are expressed in the vasculature and also regulate angiogenesis under some circumstances, but whether they also modulate lung vascular permeability is unknown. We hypothesized that stimulation of lung endothelial EphA receptors with ephrin-a1 ligand would alter pulmonary vascular permeability and tested this idea in vivo and in vitro. We found that ephrin-a1 ligand and EphA2 receptors are expressed in distal normal lung vasculature and that their expression is increased in injured lung, suggesting a link to mechanisms of increased permeability. Intravenous injection of ephrin-a1 caused a large increase in the leakage of labeled albumin into the lungs of rats within 30 min (293 +/- 27 vs. 150 +/- 6 ng/mg dry lung, P < 0.01), along with histological evidence of the formation of endothelial disruptions. In cultured lung vascular endothelial cells, stimulation with ephrin-a1 increased monolayer permeability by 44% (P < 0.01), a permeability change similar to that seen with VEGF stimulation of the same cells. Ephrin-a1 stimulation in vivo and in vitro was associated with histological evidence for disruptions of tight and adherens junctions. These observations describe a novel role for ephrin-a1 and EphA receptors in the regulation of vascular permeability in the lung.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599503      PMCID: PMC2536794          DOI: 10.1152/ajplung.90256.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  27 in total

1.  Tumor necrosis factor-alpha induction of endothelial ephrin A1 expression is mediated by a p38 MAPK- and SAPK/JNK-dependent but nuclear factor-kappa B-independent mechanism.

Authors:  N Cheng; J Chen
Journal:  J Biol Chem       Date:  2001-02-02       Impact factor: 5.157

2.  Expression of genes involved in vascular development and angiogenesis in endothelial cells of adult lung.

Authors:  Cecile J Favre; Michael Mancuso; Kevin Maas; John W McLean; Peter Baluk; Donald M McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-07-03       Impact factor: 4.733

3.  Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.

Authors:  Nikki Cheng; Dana M Brantley; Hua Liu; Qin Lin; Miriam Enriquez; Nick Gale; George Yancopoulos; Douglas Pat Cerretti; Thomas O Daniel; Jin Chen
Journal:  Mol Cancer Res       Date:  2002-11       Impact factor: 5.852

4.  Upregulation of alveolar epithelial fluid transport after subacute lung injury in rats from bleomycin.

Authors:  H G Folkesson; G Nitenberg; B L Oliver; C Jayr; K H Albertine; M A Matthay
Journal:  Am J Physiol       Date:  1998-09

5.  Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome.

Authors:  D R Thickett; L Armstrong; S J Christie; A B Millar
Journal:  Am J Respir Crit Care Med       Date:  2001-11-01       Impact factor: 21.405

6.  Viral respiratory infection increases susceptibility of young rats to hypoxia-induced pulmonary edema.

Authors:  T C Carpenter; J T Reeves; A G Durmowicz
Journal:  J Appl Physiol (1985)       Date:  1998-03

7.  Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo.

Authors:  M Corada; M Mariotti; G Thurston; K Smith; R Kunkel; M Brockhaus; M G Lampugnani; I Martin-Padura; A Stoppacciaro; L Ruco; D M McDonald; P A Ward; E Dejana
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

8.  Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression.

Authors:  Dana M Brantley-Sieders; Wei Bin Fang; Donna J Hicks; Guanglei Zhuang; Yu Shyr; Jin Chen
Journal:  FASEB J       Date:  2005-09-15       Impact factor: 5.191

9.  Cell-based angiopoietin-1 gene therapy for acute lung injury.

Authors:  Sarah D McCarter; Shirley H J Mei; Patrick F H Lai; Qiu Wang Zhang; Colleen H Parker; Renée S Suen; Roberta D Hood; Yidan D Zhao; Yupu Deng; Robin N N Han; Daniel J Dumont; Duncan J Stewart
Journal:  Am J Respir Crit Care Med       Date:  2007-02-22       Impact factor: 21.405

Review 10.  In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights.

Authors:  Bryan J McVerry; Joe G N Garcia
Journal:  Cell Signal       Date:  2005-02       Impact factor: 4.315

View more
  29 in total

Review 1.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Authors:  Elena B Pasquale
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

2.  EphA2 stimulates VCAM-1 expression through calcium-dependent NFAT1 activity.

Authors:  Steven Daniel Funk; Alexandra C Finney; Arif Yurdagul; Christopher B Pattillo; A Wayne Orr
Journal:  Cell Signal       Date:  2018-05-21       Impact factor: 4.315

3.  Transactivation of the receptor-tyrosine kinase ephrin receptor A2 is required for the low molecular weight hyaluronan-mediated angiogenesis that is implicated in tumor progression.

Authors:  Frances E Lennon; Tamara Mirzapoiazova; Nurbek Mambetsariev; Bolot Mambetsariev; Ravi Salgia; Patrick A Singleton
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

4.  Tissue Engineering of Axially Vascularized Soft-Tissue Flaps with a Poly-(ɛ-Caprolactone) Nanofiber-Hydrogel Composite.

Authors:  Dominic Henn; Kellen Chen; Katharina Fischer; Annika Rauh; Janos A Barrera; Yoo-Jin Kim; Russell A Martin; Matthias Hannig; Patricia Niedoba; Sashank K Reddy; Hai-Quan Mao; Ulrich Kneser; Geoffrey C Gurtner; Justin M Sacks; Volker J Schmidt
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-06-10       Impact factor: 4.730

5.  MicroRNA dysregulation in lung injury: the role of the miR-26a/EphA2 axis in regulation of endothelial permeability.

Authors:  Ryan J Good; Laura Hernandez-Lagunas; Ayed Allawzi; Joanne K Maltzahn; Christine U Vohwinkel; Arun K Upadhyay; Uday B Kompella; Konstantin G Birukov; Todd C Carpenter; Carmen C Sucharov; Eva Nozik-Grayck
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-07-19       Impact factor: 5.464

6.  Exploring Mechanistic Toxicity of Mixtures Using PBPK Modeling and Computational Systems Biology.

Authors:  Patricia Ruiz; Claude Emond; Evad D McLanahan; Shivanjali Joshi-Barr; Moiz Mumtaz
Journal:  Toxicol Sci       Date:  2020-03-01       Impact factor: 4.849

7.  Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage.

Authors:  Jie Liu; Xinchun Jin; Ke J Liu; Wenlan Liu
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

8.  EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis.

Authors:  Steven Daniel Funk; Arif Yurdagul; Patrick Albert; James G Traylor; Long Jin; Jin Chen; A Wayne Orr
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-01-12       Impact factor: 8.311

Review 9.  Making Connections: Guidance Cues and Receptors at Nonneural Cell-Cell Junctions.

Authors:  Ian V Beamish; Lindsay Hinck; Timothy E Kennedy
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-11-01       Impact factor: 10.005

10.  EphA2 proteomics in human keratinocytes reveals a novel association with afadin and epidermal tight junctions.

Authors:  Bethany E Perez White; Rosa Ventrella; Nihal Kaplan; Calvin J Cable; Paul M Thomas; Spiro Getsios
Journal:  J Cell Sci       Date:  2016-11-04       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.